MetaCap

Enanta Pharmaceuticals Insider Trades

NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.62-0.36 (-4.51%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
9 · $183.17K
Shares bought / sold
0 / 12.88K
Net activity
Net selling $183,167

Enanta Pharmaceuticals insider activity

Over the last 12 months, Enanta Pharmaceuticals insiders reported 36 transactions on SEC Form 4: 0 open-market purchases and 9 sales. Insiders bought $0 and sold $183,167 worth of stock, for net insider selling of $183,167. The largest seller was Luly Jay R., with $67,493 in reported sales.

The most recent filing shows Rottinghaus Scott T. (Chief Medical Officer) reporting a transaction in 1,467 shares at $13.34 on Aug 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ENTA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ENTA insider transactions

Enanta Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Aug 8, 2026Rottinghaus Scott T.Chief Medical OfficerTax withholding1,467$19.57KForm 4
Feb 12, 2026Luly Jay R.President and CEOTax withholding6,155$87.71KForm 4
Feb 12, 2026Luly Jay R.President and CEOAward15,200—Form 4
Feb 12, 2026Luly Jay R.President and CEOAward4,800—Form 4
Feb 12, 2026Kieffer Tara LynnChief Product Strategy OfficerTax withholding3,257$46.41KForm 4
Feb 12, 2026Kieffer Tara LynnChief Product Strategy OfficerAward4,987—Form 4
Feb 12, 2026Kieffer Tara LynnChief Product Strategy OfficerAward1,575—Form 4
Feb 12, 2026Or Yat SunChief Scientific OfficerTax withholding3,413$48.64KForm 4
Feb 12, 2026Or Yat SunChief Scientific OfficerAward5,225—Form 4
Feb 12, 2026Or Yat SunChief Scientific OfficerAward1,650—Form 4
Feb 12, 2026Rottinghaus Scott T.Chief Medical OfficerTax withholding3,413$48.64KForm 4
Feb 12, 2026Rottinghaus Scott T.Chief Medical OfficerAward5,225—Form 4
Feb 12, 2026Rottinghaus Scott T.Chief Medical OfficerAward1,650—Form 4
Feb 12, 2026Luu BrendanChief Business OfficerTax withholding3,257$46.41KForm 4
Feb 12, 2026Luu BrendanChief Business OfficerAward4,987—Form 4
Feb 12, 2026Luu BrendanChief Business OfficerAward1,575—Form 4
Feb 12, 2026Kowalsky Matthew PaulChief Legal OfficerTax withholding1,902$27.10KForm 4
Feb 12, 2026Kowalsky Matthew PaulChief Legal OfficerAward4,175—Form 4
Feb 12, 2026Kowalsky Matthew PaulChief Legal OfficerAward1,318—Form 4
Dec 5, 2025Capps Kathleen S.See RemarksSale323$4.60KForm 4
Dec 5, 2025Luly Jay R.President and CEOSale4,743$67.49KForm 4
Dec 5, 2025Or Yat SunChief Scientific OfficerSale2,390$34.01KForm 4
Dec 5, 2025Kieffer Tara LynnChief Product Strategy OfficerSale2,106$29.97KForm 4
Dec 5, 2025Luu BrendanChief Business OfficerSale1,394$19.84KForm 4
Dec 5, 2025Rottinghaus Scott T.Chief Medical OfficerSale798$11.36KForm 4
Dec 5, 2025Trout Harry R. IIISee RemarksSale542$7.71KForm 4
Dec 2, 2025Capps Kathleen S.See RemarksSale207$2.89KForm 4
Dec 2, 2025Trout Harry R. IIISee RemarksSale380$5.30KForm 4
Dec 1, 2025Luly Jay R.President and CEOTax withholding1,885$26.62KForm 4
Dec 1, 2025Or Yat SunChief Scientific OfficerTax withholding753$10.63KForm 4
Dec 1, 2025Kieffer Tara LynnChief Product Strategy OfficerTax withholding753$10.63KForm 4
Dec 1, 2025Luu BrendanChief Business OfficerTax withholding498$7.03KForm 4
Dec 1, 2025Capps Kathleen S.See RemarksTax withholding85$1.20KForm 4
Dec 1, 2025Trout Harry R. IIISee RemarksTax withholding105$1.48KForm 4
Nov 25, 2025Trout Harry R. IIISee RemarksAward6,463—Form 4
Nov 25, 2025Capps Kathleen S.See RemarksAward3,163—Form 4
Aug 8, 2025Rottinghaus Scott T.Chief Medical OfficerTax withholding2,217$15.50KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related